• Tuesday, Mar 02, 2021
  • Last Update : 01:51 am

Study: First vaccine dose cuts transmission, hospitalization

  • Published at 01:34 pm February 23rd, 2021
Vials with the Pfizer-BioNTech vaccine
File photo: Vials with the Pfizer-BioNTech vaccine against the coronavirus stand ready for use at the vaccination centre, in Germany on January 10, 2021 AFP

Analysis shows that the efficacy of Pfizer-BioNTech vaccine in reducing the risk of infection is 70% after the first dose which rises to 85% after a second dose

Data from two separate studies published in the UK on Monday, one in England and another in Scotland, have shown vaccines against Covid-19 are effective in cutting disease transmission and hospitalizations from the first dose.

Analysis from Public Health England has shown the vaccine manufactured by Pfizer-BioNTech reduces the risk of catching infection by more than 70% after a first dose. That risk is reduced by 85% after a second dose.

The public health body's study of real-world data also showed vaccinated people who go on to become infected are far less likely to die or be hospitalized.

Hospitalization and death from Covid-19 is reduced by over 75% in those who have received a dose of the Pfizer-BioNTech vaccine, according to the analysis.

"This crucial report shows vaccines are working -- it is extremely encouraging to see evidence that the Pfizer vaccine offers a high degree of protection against coronavirus," Health Secretary Matt Hancock said.

Britain is one of the countries hardest-hit by the Covid-19 pandemic, with 120,757 deaths. 

It was the first nation to begin mass vaccinations in December and more than 17 million people have now received at least a first vaccine dose -- one-third of the UK's adult population.

"We will see much more data over the coming weeks and months, but we should be very encouraged by these initial findings," Dr Mary Ramsay, Head of Immunization at Public Health England, said.

'National evidence’

At the same time a study in Scotland has shown the Pfizer-BioNTech and Oxford-AstraZeneca vaccinations have led to a reduction in Covid-19 admissions to hospitals after a first dose.

The study, led by the University of Edinburgh, found that by the fourth week after receiving the initial dose the Pfizer vaccine reduced the risk of hospitalization from Covid-19 by up to 85%.

The Oxford-AstraZeneca vaccine reduced the risk by 94%.

"These results are very encouraging and have given us great reasons to be optimistic for the future," Professor Aziz Sheikh, who led the research, said in a statement.

"We now have national evidence -- across an entire country -- that vaccination provides protection against Covid-19 hospitalizations.

"Roll-out of the first vaccine dose now needs to be accelerated globally to help overcome this terrible disease," he added.

The research compared the outcomes of those who had received their first jab with those who had not.

It found that vaccination was associated with an 80% reduction in hospitalization risk in the fourth week among those aged 80 years and over, when the results for both vaccines were combined.

‘Extremely promising’

The project, which used patient data to track the pandemic and the vaccine roll-out in real time, analyzed a dataset covering the entire Scottish population of 5.4 million between December 8 and February 15.

Some 1.14 million vaccines were administered to 21% of the Scottish population during the period.

The Pfizer vaccine was received by 650,000 people in Scotland, while 490,000 had the Oxford-AstraZeneca vaccine.

It is the first research to describe the effect of the vaccinations on preventing severe illness resulting in hospitalization across an entire country.

Previous results about vaccine efficacy have come from clinical trials.

The study team said the findings were applicable to other countries using the Pfizer and Oxford-AstraZeneca vaccines.

The data reported "is extremely promising," said Arne Akbar, the president of the British Society for Immunology.

"Although there does seem to be some difference in effectiveness levels measured across age groups, the reduction in hospitalizations for the older age groups is still impressively high," he said.

"We now need to understand how long-lasting this protection is for one dose of the vaccine."

52
Facebook 52
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail